CAD 0.03
(-16.67%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | -167.62 Thousand CAD | -729.71% |
2022 | 26.62 Thousand CAD | -68.62% |
2021 | 84.82 Thousand CAD | 2517.21% |
2020 | -3509.00 CAD | -109.99% |
2019 | -1671.00 CAD | 88.72% |
2018 | -14.81 Thousand CAD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q2 | -38.87 Thousand CAD | 0.0% |
2024 Q1 | -38.87 Thousand CAD | 7.23% |
2023 Q4 | -41.9 Thousand CAD | 0.0% |
2023 FY | -167.62 Thousand CAD | -729.71% |
2023 Q1 | -41.9 Thousand CAD | -14.69% |
2023 Q3 | -41.9 Thousand CAD | -0.0% |
2023 Q2 | -41.9 Thousand CAD | 0.0% |
2022 Q2 | -34.82 Thousand CAD | -365.84% |
2022 FY | 26.62 Thousand CAD | -68.62% |
2022 Q4 | -36.54 Thousand CAD | 2.08% |
2022 Q3 | -37.31 Thousand CAD | -7.16% |
2022 Q1 | 13.1 Thousand CAD | -49.89% |
2021 FY | 84.82 Thousand CAD | 2517.21% |
2021 Q2 | 24.84 Thousand CAD | 4145.6% |
2021 Q1 | -614.00 CAD | 95.49% |
2021 Q3 | 33.84 Thousand CAD | 36.23% |
2021 Q4 | 26.14 Thousand CAD | -22.75% |
2020 FY | -3509.00 CAD | -109.99% |
2020 Q1 | - CAD | 100.0% |
2020 Q3 | - CAD | 100.0% |
2020 Q2 | -6959.00 CAD | 0.0% |
2020 Q4 | -13.62 Thousand CAD | 0.0% |
2019 Q4 | -5680.00 CAD | 0.0% |
2019 Q3 | - CAD | 0.0% |
2019 Q1 | -250.00 CAD | 96.98% |
2019 FY | -1671.00 CAD | 88.72% |
2019 Q2 | - CAD | 100.0% |
2018 Q3 | -250.00 CAD | 0.0% |
2018 FY | -14.81 Thousand CAD | 0.0% |
2018 Q4 | -8280.00 CAD | -3212.0% |
2018 Q2 | - CAD | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Aquarius Surgical Technologies Inc. | 132.85 Thousand CAD | 226.175% |
Cannabix Technologies Inc. | -153.23 Thousand CAD | -9.393% |